General Information of DTT (ID: TTF8JAT)

DTT Name SLC5A2 messenger RNA (SLC5A2 mRNA) DTT Info
Gene Name SLC5A2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Bexagliflozin DMK56G0 Type 2 diabetes 5A11 Approved [1]
------------------------------------------------------------------------------------
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ISIS-SGLT2 DMDKAIC Type-2 diabetes 5A11 Phase 1 [2]
------------------------------------------------------------------------------------
15 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
10-methoxy-N(1)-methylburnamine-17-O-veratrate DMJW25X Discovery agent N.A. Investigative [3]
ACEROGENIN B DMVQ30P Discovery agent N.A. Investigative [4]
Acerogenin C DMNETSX Discovery agent N.A. Investigative [4]
Alstiphyllanine D DM2FLDJ Discovery agent N.A. Investigative [3]
Alstiphyllanine E DMTNQ5E Discovery agent N.A. Investigative [3]
Alstiphyllanine F DMKRAEW Discovery agent N.A. Investigative [3]
Burnamine-17-O-3',4',5'-trimethoxybenzoate DMBO0WI Discovery agent N.A. Investigative [3]
FORMONONETIN DM7WFZ8 Discovery agent N.A. Investigative [5]
KURAIDIN DMLDUJ1 Discovery agent N.A. Investigative [5]
KURARINONE DMH0G8W Discovery agent N.A. Investigative [5]
Kushenol N DMY13UR Discovery agent N.A. Investigative [5]
MAACKIAIN DMDHGM2 Discovery agent N.A. Investigative [5]
O-spiroketal glucoside DM3FS62 Discovery agent N.A. Investigative [6]
SERGLIFLOZIN A DM6FVCE Discovery agent N.A. Investigative [7]
Sophoraflavanone G DMBTMN5 Discovery agent N.A. Investigative [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 15 Investigative Drug(s)
Molecule Interaction Atlas

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011).
3 Alstiphyllanines E-H, picraline and ajmaline-type alkaloids from Alstonia macrophylla inhibiting sodium glucose cotransporter. Bioorg Med Chem. 2010 Mar 15;18(6):2152-2158.
4 Cyclic diarylheptanoids as Na+-glucose cotransporter (SGLT) inhibitors from Acer nikoense. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1070-4.
5 Na+-glucose cotransporter (SGLT) inhibitory flavonoids from the roots of Sophora flavescens. Bioorg Med Chem. 2007 May 15;15(10):3445-9.
6 ortho-Substituted C-aryl glucosides as highly potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors. Bioorg Med Chem. 2010 Jun 15;18(12):4422-32.
7 Novel C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents: 1,3,4-Thiadiazolylmethylphenyl glucoside congeners. Bioorg Med Chem. 2010 Mar 15;18(6):2178-2194.